NPS PHARMACEUTICALS INC Accrued Liabilities, Fair Value Disclosure
NPS PHARMACEUTICALS INC had Accrued Liabilities, Fair Value Disclosure of $3.70 million as of 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Notes
us-gaap:AccruedLiabilitiesFairValueDisclosure · last filed 2015-02-18
- 2014-12-31: Accrued Liabilities, Fair Value Disclosure $3.70M.
- 2014-09-30: Accrued Liabilities, Fair Value Disclosure $3.60M.
- 2014-06-30: Accrued Liabilities, Fair Value Disclosure $3.50M.
- 2014-03-31: Accrued Liabilities, Fair Value Disclosure $4.40M.
| Period end | Accrued Liabilities, Fair Value Disclosure |
|---|---|
| 2014-12-31 | $3.70M 10-K · filed 2015-02-18 |
| 2014-09-30 | $3.60M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $3.50M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $4.40M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $4.30M 10-K · filed 2015-02-18 |
| 2013-09-30 | $4.20M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $4.10M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $5.00M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $4.80M 10-K · filed 2014-02-18 |
| 2012-09-30 | $4.30M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $4.20M 10-Q · filed 2012-08-01 |
| 2011-12-31 | $4.90M 10-K · filed 2013-02-21 |